Member Info for oxygen

@jdt. Indeed Markets seemed to act far more rationally without such volatility prior to any social media, when you could only check the SP’s via the following days paper unless you phoned your Broker ! This obsession for instant news gets farcical at times, which helps those with agenda’s to pump the likes of Twitter knowing it gets easily swallowed !!

Enthusiasm is good, but lets not guess or allow it to cloud judgement. As onlookers we hold an investment the outcome of which remains uncertain, and that’s the enjoyment....if it doesn’t feel that way take some action. By end Q1 we could have our answer !

The “pain” is lost revenue, no more no less. As Shareholders our use is exhausted so the Company won’t be concerned one iota about us, they know what’s going on and have a secure future, irrespective. You wait or you don’t...life is pretty simple really !

Wouldn’t worry about it. It’s a non specific award from last year.

Agree timelines would suggest we’re in Phase 3b and can’t be far away from completion. Likewise abandonment would have required notice, so still all to play for.

So would normally expect a TU this week ( last year it was 23rd Jan ) ...so just as a warning if you see an RNS suddenly appear, it may not be what you were expecting. That said, AS would have some cheek not to mention progress alongside the Financials ! We live in hope.

Well the UK’s got some catching up to do given the dominant LFT Mfrg positions held by the US / Asia.....so don’t think others will be too worried just yet !

Company clearly has a lot of potential just wish CEO’s would be a little more direct. It’s a bit like that tired statement many trot out..” in line with the BOD expectations“ as if we were all sitting around the bl**dy table !! Anyway will sit on hands.

Obviously those Mkt Exptn’s weren’t very stretching otherwise those in the know wouldn’t have us quite so marked down.

YE 31/12, so a TU could be expected later this week as their Financials, at this stage, can’t be that complex. Only slight concern they’ll have is what else to say on Product development, if still its WIP, as they’ll know that’s all the Mkt now wants to hear. Silence on that wouldn’t be a good look !

Usually Mkt Exptn’s are in a range, so is that a reference to its Mid Point
as unaware which Analysts involved here....anyone ?

I wonder what shares David Williams holds in his SIPP a/c ?

Unfortunately minimal Trading regulation applies across the board these days. Only need to witness US GameStop ....over 140% of its shares shorted and when the inevitable squeeze comes its SP goes from $6 to $65 ! If Regulators sit on hands whilst more shares are shorted than available it basically open season !

Highly encouraging research ......”However, we here present a clear improvement of protein purification using affimers. There is an unmet need for validation of any affinity protein binder, i.e. antibody, affimer or other to determine their specificity and reproducibility in human plasma, as this is highly relevant for diagnostics”

@Y.....maybe best to get the Medusa boys to do the haggling. Likely those akin to market traders can squeeze margins better than any scientist ! ( with all due respect to AS )

Very difficult to put nett profit margins against any LFT. Cytiva were commissioned to put the diagnostic assay onto its proprietary point-of-care test strip platform , which suggests a Royalty payment made be involved, the level of which will depend upon distribution of development costs. Irrespective any Government procurement
involvement will require full cost analysis to ensure margins are acceptable, so I wouldn’t get too carried away just yet !

This is merely a review of the current scheme where low earners on certain benefits can already be paid £500 if tested positive. Not surprisingly the cash earmarked for this scheme ran out, hence its up for review ! What is perhaps more worrying for you lot in the UK is the idea that the Police now be given access to your Health records !

It would be rather decent of the Government if they not only spent money on PA Consultants, in looking for the fairly obvious, but also gave financial help where needed to those already spending millions in research. We probably then wouldn’t have needed to have raised so much cash recently !

The lack of precise detail flowing from the Company in respect of BAMS & LFT’s is now becoming somewhat of a joke, almost as if the Diagnostics Division is being air brushed off the page. Accept Private Shareholders count for little unless Funds are required but some respect for our patience wouldn’t go amiss, irrespective of any NDA’s covering financial/technical detail.

Wouldn’t worry about tomorrow, next week or next month unless you’re jumping in and out of this one. GB has recognised this Company’s involvement in the fast growing MS post pandemic Market which will be huge, yet barely touched by the previous team. Bet he can’t believe his luck !